BCDA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 23.90%

Insider Buying (Last 12 Months): $59,844.68

Insider Selling (Last 12 Months): $55,814.86

BioCardia Insider Trading History Chart

BioCardia Share Price & Price History

^$0.37

+0.30 (1.20%)

As of 04/17/2024 01:00 AM ET

Days: 30 | 90 | 365

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

BioCardia Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/28/2024	Peter Altman	CEO	Buy	500	$0.39	$195.00	555,947
2/13/2024	Peter Altman	CEO	Buy	108,108	$0.46	$49,729.68	555,447
1/19/2024	Phillip Md Et Al Frost	Major Shareholder	Sell	129,802	$0.43	$55,814.86	1,896,025
5/26/2023	Peter Altman	CEO	Buy	6,200	$1.60	$9,920.00	469,239
1/11/2023	Peter Altman	CEO	Buy	100	$1.87	$187.00	353,715
12/16/2022	Phillip Md Et Al Frost	Major Shareholder	Buy	595,238	$1.68	$999,999.84	2,025,827
10/10/2022	David Mcclung	CFO	Buy	2,000	$2.07	$4,140.00	78,518
9/23/2022	Peter Altman	CEO	Buy	1,400	$1.87	$2,618.00	328,447
9/21/2022	Peter Altman	CEO	Buy	2,750	$1.92	$5,280.00	323,947
6/10/2022	Peter Altman	CEO	Buy	4,500	$1.46	$6,570.00	321,197
5/13/2022	Peter Altman	CEO	Buy	2,698	$1.38	$3,723.24	348,143
5/11/2022	Peter Altman	CEO	Buy	1,000	$1.30	$1,300.00	334,143
4/28/2022	Peter Altman	CEO	Buy	2,300	$1.59	$3,657.00	330,443
4/18/2022	Peter Altman	CEO	Buy	13,500	$1.39	$18,765.00	328,143
11/18/2021	Peter Altman	CEO	Buy	5,000	$2.20	$11,000.00
8/17/2021	Peter Altman	CEO	Buy	3,500	$2.94	$10,290.00	232,909

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

SEC Filings (Institutional Ownership Changes) for BioCardia (NASDAQ:BCDA)

20.57% of BioCardia stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

BioCardia Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/26/2024	Virtu Financial LLC	41,348	$27K	0.0%	N/A	0.160%
11/7/2023	CM Management LLC	600,000	$0.26M	0.3%	+74.9%	2.775%
8/11/2023	BlackRock Inc.	33,013	$88K	0.0%	N/A	0.161%
8/11/2023	Geode Capital Management LLC	145,155	$0.39M	0.0%	+50.3%	0.710%
8/4/2023	CM Management LLC	343,000	$0.92M	0.9%	+4.3%	1.677%
7/24/2023	Vontobel Holding Ltd.	30,751	$82K	0.0%	+93.5%	0.150%
5/16/2023	Family Management Corp	77,500	$0.15M	0.0%	-45.5%	0.384%
5/15/2023	AIGH Capital Management LLC	509,151	$0.99M	0.4%	-14.5%	2.523%
4/12/2023	Vontobel Holding Ltd.	15,895	$31K	0.0%	N/A	0.079%
2/16/2023	AIGH Capital Management LLC	595,237	$1.24M	0.4%	N/A	2.969%
2/10/2023	Advisor Group Holdings Inc.	47,843	$100K	0.0%	-9.5%	0.239%
11/15/2022	Family Management Corp	142,186	$0.28M	0.1%	N/A	0.797%
8/15/2022	Millennium Management LLC	28,312	$42K	0.0%	N/A	0.162%
5/13/2022	Renaissance Technologies LLC	13,700	$28K	0.0%	N/A	0.081%
5/13/2022	Vanguard Group Inc.	650,523	$1.35M	0.0%	+57.9%	3.856%
5/13/2022	Dimensional Fund Advisors LP	27,407	$57K	0.0%	N/A	0.162%
5/4/2022	Commonwealth Equity Services LLC	49,978	$0.10M	0.0%	+18.1%	0.296%
1/31/2022	Commonwealth Equity Services LLC	42,307	$82K	0.0%	+156.5%	0.251%
11/5/2021	Advisor Group Holdings Inc.	39,257	$0.12M	0.0%	-8.4%	0.233%
10/29/2021	Commonwealth Equity Services LLC	16,492	$51K	0.0%	N/A	0.098%
9/17/2021	Virtu Financial LLC	33,264	$0.13M	0.0%	N/A	0.197%
8/25/2021	Marshall Wace LLP	21,680	$86K	0.0%	-45.7%	0.129%
8/16/2021	Marshall Wace LLP	21,680	$86K	0.0%	-45.7%	0.129%
8/13/2021	Renaissance Technologies LLC	102,230	$0.41M	0.0%	-66.5%	0.609%
8/13/2021	Geode Capital Management LLC	76,825	$0.30M	0.0%	+23.6%	0.457%
8/13/2021	Vanguard Group Inc.	411,969	$1.64M	0.0%	+67.8%	2.453%
8/10/2021	CM Management LLC	329,000	$1.31M	0.9%	+5.1%	1.959%
8/6/2021	Magnus Financial Group LLC	15,000	$60K	0.0%	N/A	0.089%
5/19/2021	Squarepoint Ops LLC	46,945	$0.20M	0.0%	N/A	0.280%
5/13/2021	Renaissance Technologies LLC	305,200	$1.33M	0.0%	N/A	1.817%
5/12/2021	Geode Capital Management LLC	62,168	$0.27M	0.0%	+175.6%	0.370%
5/12/2021	CM Management LLC	313,100	$1.36M	1.0%	+36.1%	1.864%
2/9/2021	Bank of New York Mellon Corp	16,294	$56K	0.0%	N/A	0.131%
2/5/2021	CM Management LLC	230,000	$0.80M	0.7%	N/A	1.851%
8/17/2020	Jane Street Group LLC	14,688	$35K	0.0%	N/A	0.214%
8/14/2020	Captrust Financial Advisors	659,179	$1.62M	0.0%	N/A	9.626%
8/14/2020	Advisor Group Holdings Inc.	85,002	$0.20M	0.0%	-7.7%	1.241%
5/18/2020	Advisor Group Holdings Inc.	92,083	$0.31M	0.0%	N/A	1.349%

Data available starting January 2016

BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.

Today's Range

Now: $0.37

$0.36

$0.38

50 Day Range

MA: $0.42

$0.36

$0.58

52 Week Range

Now: $0.37

$0.36

$2.92

Volume

31,756 shs

Average Volume

341,309 shs

Market Capitalization

$9.84 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.47

Who are the company insiders with the largest holdings of BioCardia?: BioCardia's top insider investors include:
Phillip Md Et Al Frost (Major Shareholder)
Peter Altman (CEO)
David Mcclung (CFO)
Learn More about top insider investors at BioCardia.